<SEC-DOCUMENT>0001206774-23-000992.txt : 20230828
<SEC-HEADER>0001206774-23-000992.hdr.sgml : 20230828
<ACCEPTANCE-DATETIME>20230828060549
ACCESSION NUMBER:		0001206774-23-000992
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230828
DATE AS OF CHANGE:		20230828

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRANSCAT INC
		CENTRAL INDEX KEY:			0000099302
		STANDARD INDUSTRIAL CLASSIFICATION:	INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825]
		IRS NUMBER:				160874418
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0325

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-274050
		FILM NUMBER:		231209987

	BUSINESS ADDRESS:	
		STREET 1:		35 VANTAGE POINT DRIVE
		CITY:			ROCHESTER
		STATE:			NY
		ZIP:			14624
		BUSINESS PHONE:		5853527777

	MAIL ADDRESS:	
		STREET 1:		35 VANTAGE POINT DRIVE
		CITY:			ROCHESTER
		STATE:			NY
		ZIP:			14624

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSMATION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>trns4234271-424b3.htm
<DESCRIPTION>PROSPECTUS FILED PURSUANT TO RULE 424(B)(3)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="background-color: white"><B>Filed Pursuant
to Rule 424(b)(3)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="background-color: white"><B>File No. 333-
274050</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="trns4234271-s3x1x1x1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center"><B>Transcat, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center"><B>271,820 Shares of Common Stock Offered by the Selling
Shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">This prospectus relates to the
offer and resale by the selling shareholders identified herein of up to 271,820 shares of our common stock, par value $0.50 per share
(&ldquo;Common Stock&rdquo;). This prospectus provides you with a general description of the shares of Common Stock. You should carefully
read this prospectus and the documents incorporated by reference before buying any of the shares of Common Stock being offered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We are registering the offer
and sale of the shares of the Common Stock owned by the selling shareholders to satisfy registration rights we have granted to the selling
shareholders pursuant to a registration rights agreement dated as of August 8, 2023 (the &ldquo;Registration Rights Agreement&rdquo;).
We have agreed to bear all of the expenses incurred in connection with the registration of the Common Stock covered by this prospectus.
The selling shareholders will pay or assume brokerage commissions and similar charges, if any, incurred in the sale of the shares of Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The registration of shares of
Common Stock hereunder does not mean that the selling shareholders will actually offer or sell the full number of shares being registered
pursuant to this prospectus. The selling shareholders may sell the shares of Common Stock registered hereby from time to time. The shares
of Common Stock may be offered and sold by the selling shareholders through public or private transactions, at market prices prevailing
at the time of sale or at negotiated prices. The selling shareholders may retain underwriters, dealers or agents from time to time. For
additional information on the methods of sale, you should refer to the section entitled &ldquo;Plan of Distribution&rdquo; in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We are not selling any shares
of our Common Stock pursuant to this prospectus, and we will not receive any proceeds from any sale by selling shareholders of the shares
of Common Stock covered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Our Common Stock is traded on
the Nasdaq Global Market under the symbol &ldquo;TRNS.&rdquo; On August 15, 2023, the last reported sale price of our Common Stock on
the Nasdaq Global Market was $94.18 per share.</P>

<P STYLE="margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15pt"><B>Investing in our Common Stock
involves risk. You should carefully read the information included and incorporated by reference into this prospectus for a discussion
of the factors you should carefully consider in determining whether to invest in our Common Stock, including the discussion of risks described
under &ldquo;Risk Factors&rdquo; on page 7 of this prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">___________________</P>

<P STYLE="margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15pt"><B>Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy
of this prospectus. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center">The date of this prospectus is August 25, 2023.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-transform: uppercase; text-align: center"><A NAME="toc"></A>TABLE OF CONTENTS</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt; width: 90%"><A HREF="#a_001">ABOUT THIS PROSPECTUS</A></TD>
    <TD STYLE="padding-bottom: 6pt; width: 10%; text-align: right"><A HREF="#a_001">1</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_002">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_002">2</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_003">PROSPECTUS SUMMARY</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_003">4</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_004">THE COMPANY</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_004">5</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_005">RISK FACTORS</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_005">7</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_006">WHERE YOU CAN FIND MORE INFORMATION</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_006">7</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_007">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_007">8</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_008">DESCRIPTION OF COMMON STOCK</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_008">9</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_009">USE OF PROCEEDS</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_009">12</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_010">SELLING SHAREHOLDERS</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_010">12</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_011">PLAN OF DISTRIBUTION</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_011">13</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 6pt"><A HREF="#a_012">LEGAL MATTERS</A></TD>
    <TD STYLE="padding-bottom: 6pt; text-align: right"><A HREF="#a_012">16</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_013">EXPERTS</A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_013">16</A></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_001"></A>ABOUT THIS PROSPECTUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">This prospectus relates to the
resale by the selling shareholders (the &ldquo;Selling Shareholders), as defined in the section of this prospectus entitled &ldquo;Selling
Shareholders,&rdquo; of up to 271,820 shares of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">This prospectus is part of a
registration statement that we have filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) pursuant to which the Selling
Shareholders named herein may, from time to time, offer and sell or otherwise dispose of the shares of Common Stock covered by this prospectus.
You should rely only on the information contained in, or incorporated by reference into, this prospectus and any applicable prospectus
supplement we have authorized for use in connection with this offering. We have not authorized anyone to provide you with additional information
or information different from that contained in, or incorporated by reference into, this prospectus and any applicable prospectus supplement.
This prospectus is not an offer to sell or the solicitation of an offer to buy our securities in any circumstances under which the offer
or solicitation is unlawful or in any state or other jurisdiction where the offer is not permitted. The information contained in this
prospectus, any applicable prospectus supplement, and the documents incorporated by reference herein and therein, is accurate only as
of their respective dates, regardless of the time of delivery of this prospectus, any applicable prospectus supplement, or any sale of
a security. Our business, financial condition, results of operations and prospects may have changed since such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">It is important for you to read
and consider all information contained in this prospectus and any prospectus supplement, including the documents incorporated by reference,
in making your investment decision. This prospectus contains summaries of certain provisions contained in some of the documents described
herein, but reference is made to the actual documents for complete information. Copies of some of the documents referred to herein have
been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a
part, and you may obtain copies of those documents as described below under the section entitled &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">This prospectus contains forward-looking
statements that are subject to a number of risks and uncertainties, many of which are beyond our control. Please read the sections entitled
&ldquo;Risk Factors&rdquo; and &ldquo;Cautionary Statement Regarding Forward-Looking Statements.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15pt">Unless the context otherwise requires,
references in this prospectus to &ldquo;Transcat,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; and &ldquo;our&rdquo;
refer to Transcat, Inc. and its subsidiaries, unless the context clearly indicates otherwise.</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_002"></A>CAUTIONARY STATEMENT REGARDING
FORWARD-LOOKING STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">This prospectus contains forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations,
estimates, beliefs, assumptions and predictions of future events and are identified by words such as &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;designed,&rdquo; &ldquo;could,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo;
&ldquo;will,&rdquo; &ldquo;would&rdquo;, &ldquo;can&rdquo;, &ldquo;plan,&rdquo; and other similar words. Forward-looking statements are
not statements of historical fact and thus are subject to risks, uncertainties and other factors that could cause actual results to differ
materially from historical results or those expressed in such forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">These forward-looking statements
are not guarantees of future performance, nor should they be relied upon as representing management&rsquo;s views as of any subsequent
date. Forward-looking statements involve significant risks and uncertainties and actual results may differ materially from those presented,
either expressed or implied, in this prospectus, any prospectus supplement, and the documents we incorporate by reference, including among
others, statements regarding our strategy, future operations, financial objectives, prospects, plans, objectives of management and expected
performance levels are forward-looking statements. Factors that might cause such differences include, but are not limited to:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the impact of general economic conditions on our business, including inflation;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the impact of and our response to widespread public health crises;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the highly competitive nature of the industries in which we compete and in the nature of our two business segments;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the concentration of our customers in the life science and other FDA-regulated and industrial manufacturing industries;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>an impairment of goodwill or intangible assets;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>tariffs imposed by the U.S. and other countries and changes in trade relations;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability to successfully complete and integrate business acquisitions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">cybersecurity risks, including any breach in security of our information systems, the occurrence of a cyber incident or deficiency
in cyber security;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the risk of significant disruptions in our information technology systems;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our ability to recruit, train and retain quality employees, skilled technicians and senior management;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>fluctuations in our operating results;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our ability to achieve or maintain adequate utilization and pricing rates for our technical service providers and our ability to charge
adequate rates for those services;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>competition in the rental market;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability to adapt and update our technology;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our reliance on our enterprise resource planning system;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>supply chain delays or disruptions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the risks related to current and future indebtedness;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>foreign currency rate fluctuations;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability to adequately enforce and protect our intellectual property;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>adverse weather events, other catastrophes or natural disasters;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the volatility of our stock price;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the relatively low trading volume of our Common Stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>changes in tax rates;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>changes in accounting standards, legal requirements and listing standards; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>legal and regulatory risks related to our international operations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We caution you not to place undue
reliance on any forward-looking statements, which speak only as of the date made, and advise that various factors, including those described
above, could affect our financial performance and could cause our actual results or circumstances for future periods to differ materially
from those anticipated or projected. See &ldquo;Risk Factors&rdquo; and also &ldquo;Risk Factors&rdquo; in Item IA of Part I of our Annual
Report on Form 10-K for the fiscal year ended March 25, 2023, which is incorporated herein by reference, for further information. Except
as required by law, we do not undertake, and specifically disclaim any obligation to publicly release any revisions to any forward-looking
statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements.</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_003"></A>PROSPECTUS SUMMARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt"><I>This summary highlights, and
is qualified in its entirety by, the more detailed information included elsewhere or incorporated by reference in this prospectus. This
summary does not contain all of the information that may be important to you. You should read and carefully consider the entire prospectus,
especially as described in &ldquo;Risk Factors,&rdquo; before deciding to invest in the Common Stock.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; background-color: white"><B>The Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We are a leading provider of
accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test,
measurement and control instrumentation. We are focused on providing services and products to highly regulated industries, particularly
the life science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses. Additional
industries served include industrial manufacturing; energy and utilities, including oil and gas; chemical manufacturing; FAA-regulated
businesses, including aerospace and defense and other industries that require accuracy in their processes, confirmation of the capabilities
of their equipment, and for which the risk of failure is very costly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We offer a variety of services
and solutions including permanent and periodic onsite services, mobile calibration services, pickup and delivery and in-house services.
As of June 24, 2023, we operated 28 calibration service centers strategically located across the United States, Puerto Rico, Canada, and
Ireland. We also serve our customers onsite at their facilities for daily, weekly or longer-term periods. In addition, we have several
imbedded customer-site locations that we refer to as &ldquo;client-based labs,&rdquo; where we provide calibration services, and in some
cases other related services, exclusively for the customer and where we reside and work every day. We also have a fleet of mobile calibration
laboratories that can provide service at customer sites which may not have the space or utility capabilities we require to service their
equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We also operate as a leading
value-added distributor that sells and rents national and proprietary brand instruments to customers globally. Through our website, in-house
sales team and printed and digital marketing materials, we offer access to more than 140,000 test, measurement and control instruments,
including products from approximately 550 leading brands. Most instruments we sell and rent require calibration service to ensure that
they maintain the most precise measurements. By having the capability to calibrate these instruments at the time of sale and at regular
post-sale intervals, we can give customers a value-added service that most of our competitors are unable to provide. Calibrating before
shipping means the customer can place their instruments into service immediately upon receipt, reducing downtime.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We were incorporated under the
laws of the State of Ohio in 1964. Our principal executive office is located at 35 Vantage Point Drive, Rochester, New York 14624, and
our telephone number is (585) 352-7777. Our website address is www.transcat.com. The information contained on, or that can be accessed
through, our website is not a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual
reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; background-color: white"><B>The Offering</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">Common Stock Offered</TD>
    <TD STYLE="text-align: justify; width: 75%; padding-right: 0pt; padding-left: 5.4pt">All of the 271,820 shares of Common Stock offered by this prospectus are being sold by the&nbsp;Selling Shareholders.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Use of Proceeds</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 5.4pt; text-align: justify">We will not receive any proceeds from the sale of&nbsp;shares of Common Stock&nbsp;offered by this prospectus.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">NASDAQ Global Market Trading Symbol</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 5.4pt">TRNS</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_004"></A>THE COMPANY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We are a leading provider of
accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test,
measurement and control instrumentation. We are focused on providing services and products to highly regulated industries, particularly
the life science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses. Additional
industries served include FAA-regulated businesses, including aerospace and defense industrial manufacturing; energy and utilities, including
oil and gas and alternative energy; and other industries that require accuracy in their processes, confirmation of the capabilities of
their equipment, and for which the risk of failure is very costly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We conduct our business through
two operating segments: service (&ldquo;Service&rdquo;) and distribution (&ldquo;Distribution&rdquo;). Through our Service segment, we
offer calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services, a majority
of which are processed through our proprietary asset management system, CalTrak&reg; and our online customer portal, C3&reg;. Our Service
model is flexible, and we cater to our customers&rsquo; needs by offering a variety of services and solutions including permanent and
periodic onsite services, mobile calibration services, pickup and delivery, and in-house services. As of June 24, 2023, we operated 28
calibration service centers strategically located across the United States, Puerto Rico, Canada, and Ireland. We also serve our customers
onsite at their facilities for daily, weekly or longer-term periods. In addition, we have several imbedded customer-site locations that
we refer to as &ldquo;client-based labs,&rdquo; where we provide calibration services, and in some cases other related services, exclusively
for the customer and where we reside and work every day. We also have a fleet of mobile calibration laboratories that can provide service
at customer sites which may not have the space or utility capabilities we require to service their equipment. Through our acquisition
strategy, we have been focused on building out our Services segment by entering adjacent and complimentary markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Through our Distribution segment,
we sell and rent national and proprietary brand instruments to customers globally. Through our website, in-house sales team and printed
and digital marketing materials, we offer access to more than 140,000 test, measurement and control instruments, including products from
approximately 550 leading brands. Most instruments we sell and rent require calibration service to ensure that they maintain the most
precise measurements. By having the capability to calibrate these instruments at the time of sale and at regular post-sale intervals,
we can give customers a value-added service that most of our competitors are unable to provide. Calibrating before shipping means the
customer can place their instruments into service immediately upon receipt, reducing downtime. Other value-added options we offer through
our Distribution segment include equipment kitting (which is especially valued in the power generation sector), equipment rentals and
used equipment sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Our commitment to quality goes
beyond the services and products we deliver. Our sales, customer service and support teams provide expert advice, application assistance
and technical support to our customers. Since calibration is an intangible service, our customers rely on us to uphold high standards
and provide integrity in our people and processes.</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-indent: 0in">Our Strategy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Our two operating segments are
highly complementary in that their offerings are of value to customers within the same industries. Our strategy is to leverage the complementary
nature of our operating segments in ways that add value for all customers who select Transcat as their source for test and measurement
equipment and/or calibration and laboratory instrument services. We strive to differentiate ourselves within the markets we serve and
build barriers to competitive entry by offering a broad range of products and services and by integrating these solutions in a value-added
manner to benefit our customers&rsquo; operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We are committed to capital,
people and leadership investments, advancing our &ldquo;Operational Excellence&rdquo; initiative. This initiative is resulting in increased
productivity and operational efficiency and further differentiation from our competitors as we leverage technology, automation, and process
improvements to enhance our effectiveness and our customers&rsquo; experiences. We also continued Transcat University&rsquo;s build-a-tech
program. This program attracts fresh talent to the organization and provides training and career advancement opportunities for our existing
employees. Our Operational Excellence initiative is a multi-year, ever-evolving program designed to create an infrastructure that supports
our strategic goals over a longer timeframe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Within the Service segment, our
strategy is to drive double-digit revenue growth through both organic expansion and acquisitions. We have adopted an integrated sales
model to drive sales and capitalize on the cross-selling opportunities between our two segments, especially leveraging our Distribution
relationships to develop new Service relationships. We leverage these relationships with our unique value proposition which resonates
strongly with customers who rely on accredited calibration services and/or laboratory instrument services to maintain the integrity of
their processes and/or meet the demands of regulated business environments. Our customer base values our superior quality programs and
requires precise measurement capability in their processes to minimize risk, waste and defects. We execute this strategy by leveraging
our quality programs, metrology expertise, geographical footprint, qualified technicians, breadth of capabilities, and tailored service
delivery options. Together, this allows us to meet the most rigorous quality demands of our most highly regulated customers while simultaneously
being nimble enough to meet their business needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We expect to continue to grow
our Service business organically by taking market share from other third-party providers and original equipment manufacturers, as well
as by targeting the outsourcing of in-house calibration labs as multi-year client-based lab contracts. We believe an important element
in taking market share is our ability to expand into new technical capabilities and adjacent service solutions that are in demand by our
current and target customer base.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The other component to our Service
growth strategy is acquisitions. There are three drivers of our acquisition strategy: geographic expansion, increased capabilities and
infrastructure leverage. The majority of our acquisition opportunities have been in the $500 thousand to $10 million annual revenue range,
and we are disciplined in our approach to selecting target companies. One focus of our Operational Excellence initiative is to strengthen
our acquisition integration process, allowing us to capitalize on acquired sales and cost synergies at a faster pace.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Our Distribution segment strategy
is to be the premier distributor and rental source of leading test and measurement equipment while also providing cross-selling opportunities
for our Service segment.</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0in">Through our vendor relationships
we have access to more than 140,000 products, which we market to our existing and prospective customers both with and without value-added
service options that are unique to Transcat. In addition to offering pre-shipment value-added services, we offer our customers the options
of renting selected test and measurement equipment or buying used equipment, furthering our ability to answer all of our customers&rsquo;
test and measurement equipment needs. We continuously evaluate our offerings to add new in-demand vendors or products, or remove less
relevant vendors and products. Our equipment rental business continues to be a strong growth segment for us and helps support our Distribution
and Service segment growth strategies. Having new, used and rental equipment further differentiates us from our Service segment competitors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We see these various methods
of meeting our Distribution customers&rsquo; needs as a way to differentiate ourselves and to diversify this segment&rsquo;s customer
base from its historically niche market. This differentiation and diversification strategy has been deliberately instituted in recent
years as a means to mitigate the effect of price-driven competition and to lessen the impact that any particular industry or market will
have on the overall performance of this segment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We believe our combined Service
and Distribution segment offerings, experience, technical expertise and integrity create a unique and compelling value proposition for
our customers, and we intend to continue to grow our business through organic revenue growth and business acquisitions. We consider the
attributes of our Service segment, which include higher gross margins and recurring revenue streams from customers in regulated industries
to be more compelling and scalable than our legacy Distribution segment. For this reason, we expect our Service segment to be the primary
source of revenue and earnings growth in future fiscal years.&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_005"></A>RISK FACTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Investing in our Common Stock
involves risks. Before making an investment decision, you should carefully consider the specific risks set forth under the caption &ldquo;Risk
Factors&rdquo; in the applicable prospectus supplement, if any, and under the caption &ldquo;Risk Factors&rdquo; in our filings with the
SEC, which are incorporated by reference into this prospectus. See &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_006"></A>WHERE YOU CAN FIND MORE INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We file annual, quarterly and
current reports, proxy statements and other information with the SEC. Our filings with the SEC are available to the public through the
SEC's website at www.sec.gov. Our annual, quarterly and current reports and amendments to those reports, if any, are also available via
the internet at our website, www.transcat.com, by following the links to &ldquo;Investor Relations&rdquo; and &ldquo;SEC Filings.&rdquo;
The information on, or accessible through, our internet site, or any other internet site described herein, is not a part of, and is not
incorporated or deemed to be incorporated by reference in, this prospectus, and you should not consider it to be a part of this prospectus.
We will provide to each person, including any beneficial owner, to whom a prospectus is delivered a copy of any or all of the information
that has been incorporated by reference in the prospectus but not delivered with the prospectus. In addition, you may request copies of
our filings with the SEC, including the documents listed below under the heading &ldquo;Incorporation of Certain Information by Reference,&rdquo;
at no cost, by calling us at (585) 352-7777 or by writing to us at: Transcat, Inc., Attn: Corporate Secretary, 35 Vantage Point Drive,
Rochester, New York 14624.</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We have filed with the SEC a
registration statement under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), relating to the offering of these
securities. The registration statement, including the attached exhibits, contains additional relevant information about us and the Common
Stock. This prospectus does not contain all of the information set forth in the registration statement. You may review a copy of the registration
statement and the documents incorporated by reference therein through the SEC&rsquo;s internet web site referred to above.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_007"></A>INCORPORATION OF CERTAIN INFORMATION
BY REFERENCE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">THIS PROSPECTUS INCORPORATES
DOCUMENTS BY REFERENCE THAT ARE NOT PRESENTED IN OR DELIVERED WITH THIS PROSPECTUS. YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED
IN THIS PROSPECTUS AND IN THE DOCUMENTS THAT WE HAVE INCORPORATED BY REFERENCE INTO THIS PROSPECTUS. WE HAVE NOT AUTHORIZED ANYONE TO
PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT FROM OR IN ADDITION TO THE INFORMATION CONTAINED IN THIS DOCUMENT AND&nbsp;INCORPORATED
BY REFERENCE INTO THIS PROSPECTUS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The
SEC allows us to incorporate by reference into this prospectus certain information we file with it, which means that we can disclose important
information by referring you to those documents.&nbsp;</FONT>The information incorporated by reference is considered to be part of this
prospectus. Because we are incorporating by reference future filings with the SEC, this prospectus is continually updated and those future
filings may modify or supersede some of the information included or incorporated in this prospectus. We incorporate by reference all the
documents listed below and all documents subsequently filed with the SEC <FONT STYLE="background-color: white">under Sections 13(a), 13(c),
14, or 15(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), on or after (i) the date of the initial
registration statement and prior to effectiveness of the registration statement, and (ii) the date of this prospectus and prior to the
completion or termination of the offering under this prospectus; provided, however, that we are not incorporating, in each case, any documents
or information deemed to have been furnished and not filed in accordance with SEC rules</FONT>:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15.1pt"></TD><TD STYLE="width: 20.9pt">&#9679;</TD><TD STYLE="text-align: justify">Our Annual Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/0000099302/000143774923016752/trns20230325_10k.htm">Form 10-K</A> for the fiscal year ended March 25, 2023, filed with the SEC on June 6,
2023, including the information specifically incorporated by reference into the Form 10-K from our definitive proxy statement for the
2023 Annual Meeting of Shareholders filed on July 20, 2023.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15.1pt"></TD><TD STYLE="width: 20.9pt">&#9679;</TD><TD STYLE="text-align: left">Our Quarterly Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/0000099302/000143774923021645/trns20230627_10q.htm">Form 10-Q</A> for the quarter ended June 24, 2023, filed with the SEC on August 2, 2023.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15.1pt"></TD><TD STYLE="width: 20.9pt">&#9679;</TD><TD STYLE="text-align: left">Our Current Reports on Form 8-K filed with the SEC on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/0000099302/000120677423000417/trns4179691-8k.htm">March 28, 2023</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/0000099302/000120677423000712/trns4202311-8k.htm">May 22, 2023 (Film No. 23945380)</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/0000099302/000143774923019748/trns20230711_8k.htm">July&nbsp;12,&nbsp;2023</A>, and <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/99302/000143774923022398/trns20230802_8k.htm">August 8, 2023</A>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15.1pt"></TD><TD STYLE="width: 20.9pt">&#9679;</TD><TD STYLE="text-align: justify">The description of our Common Stock, par value $0.50 per share, contained in Amendment Number 1 to our Registration Statement on
                                                                     <A HREF="http://www.sec.gov/Archives/edgar/data/99302/0000950152-98-000716.txt">Form S-3</A> (Registration No. 333-42345), filed with the SEC on February 5, 1998, <A HREF="http://www.sec.gov/Archives/edgar/data/99302/000120677419001847/trns3599941-ex41.htm">Exhibit 4.1</A> to our Annual Report on Form 10-K for the
                                                                     fiscal year ended March 30, 2019, filed with the SEC on June 7, 2019, and any amendment or report filed for the purpose of updating
                                                                     such description.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Nothing in this prospectus shall
be deemed to incorporate information furnished, but not filed, with the SEC, including pursuant to Item 2.02 or Item 7.01 of Form 8-K
and any corresponding information or exhibit furnished under Item 9.01 of Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Information in this prospectus
supersedes related information in the documents listed above and information in subsequently filed documents supersedes related information
in both this prospectus and the incorporated documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">To obtain copies of these filings,
see &ldquo;Where You Can Find More Information&rdquo; in this prospectus.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_008"></A>DESCRIPTION OF COMMON STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt">Introduction</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The following section describes
the material features and rights of our Common Stock. The summary does not purport to be exhaustive and is qualified in its entirety by
reference to our Articles of Incorporation, as amended (the &ldquo;Articles&rdquo;) and our Code of Regulations, as amended (the &ldquo;Code
of Regulations&rdquo;), each of which is filed as an exhibit to the Registration Statement of which this prospectus is a part, and to
applicable sections of the Ohio General Corporation Law (the &ldquo;OGCL&rdquo;).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt">General</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We are authorized to issue up
to 30,000,000 shares of Common Stock. Each share of Common Stock entitles the holder to the same rights, and is the same in all respects,
as each other share of Common Stock. Holders of Common Stock are entitled to: (i) one vote per share on all matters requiring a shareholder
vote; (ii) a ratable distribution of dividends, if and when, declared by the board of directors (the &ldquo;Board&rdquo;); and (iii) in
the event of a liquidation, dissolution or winding up of us, to share ratably in all assets remaining available for distribution to them
after payment of liabilities. Holders of Common Stock, as such, have no conversion, preemptive or other subscription rights, and there
are no redemption provisions applicable to the Common Stock. The shares of Common Stock being offered by this prospectus are be fully
paid and nonassessable.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt">Dividends</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Our credit agreement, as amended,
limits our ability to pay cash dividends to $10.0 million in any fiscal year. We have not declared any cash dividends since our inception
and have no current plans to pay any dividends in the foreseeable future.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify">Transfer Agent &amp; Registrar</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The transfer agent and registrar
for our Common Stock is Computershare.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify">Listing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Our Common Stock is listed on
the Nasdaq Global Market under the trading symbol &ldquo;TRNS.&rdquo;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify">Anti-takeover Effects of Certain Provisions in
our Articles of Incorporation, Code of Regulations and the OGCL</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify"><U>Articles of Incorporation and Code of Regulations</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Some provisions of our Articles
and Code of Regulations may be deemed to have an anti-takeover effect and may collectively operate to delay, defer or prevent a tender
offer, a proxy contest or takeover attempt that a shareholder might consider in his or her best interest, including those attempts that
might result in a premium over the market price for the shares held by our shareholders. These provisions are intended to discourage certain
types of coercive takeover practices and inadequate takeover bids. This also encourages persons seeking to acquire control of us to negotiate
with us first. As a result, shareholders who might desire to participate in such transactions may not have an opportunity to do so. In
addition, these provisions will also render the removal of our Board or management more difficult. The following discussion is a summary
of certain material provisions of our Articles and Code of Regulations, copies of which are filed as exhibits to the Registration Statement
of which this prospectus is a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Our Articles require the affirmative
vote of the holders of at least 75% of the capital stock of the Company entitled to vote in order to authorize: (i) any merger or consolidation
of the Company with any other corporation if such transaction would otherwise by law require a vote of the shareholders; (ii) any combination
or majority share acquisition with or by any corporation if such transaction would otherwise by law require a vote of the shareholders;
or (iii) any lease, sale, exchange, transfer or other disposition of all or substantially all of the assets of the Company to any other
person or entity; if, in any such event, such other corporation, person or entity is the beneficial owner of ten percent or more of the
outstanding capital stock of the Company entitled to vote thereon. Notwithstanding the forgoing, such restrictions do not apply if the
Company&rsquo;s Board of Directors approves a memorandum of understanding with the other corporation, person or entity prior to the time
it becomes the owner of ten percent or more of the outstanding shares of the Company&rsquo;s capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Additionally, the affirmative
vote of the holders of at least 75% of the capital stock of the Company entitled to vote is required to amend, alter or repeal any of
the foregoing provisions of our Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Finally, the Board is divided
into three classes, and our Code of Regulations state that the members of each class are elected for a term of three years and only one
class of directors is elected annually. Thus, it would take at least two annual elections to replace a majority of our Board.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify"><U>Ohio General Corporation Law</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Certain provisions of the OGCL
make a change in control of an Ohio corporation more difficult. Below is a summary of the Ohio anti-takeover statutes.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify">Ohio Control Share Acquisition Statute</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The OGCL provides that certain
notice and informational filings, and special shareholder meeting and voting procedures, must occur prior to the acquisition of an issuer&rsquo;s
shares that would entitle the acquirer to exercise or direct the voting power of the issuer in the election of directors within any of
the following</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0in">ranges: (i) one-fifth or more but
less than one-third of such voting power, (ii) one-third or more but less than a majority of such voting power; or (iii) a majority or
more of such voting power.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The Ohio Control Share Acquisition
Statute does not apply to a corporation if its articles of incorporation or code of regulations so provide. We have not opted out of the
application of the Ohio Control Share Acquisition Statute.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify">Ohio Merger Moratorium Statute</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Chapter 1704 of the OGCL addresses
a range of business combinations and other transactions (including mergers, consolidations, asset sales, loans, disproportionate distributions
of property and disproportionate issuances or transfers of shares or rights to acquire shares) between an Ohio corporation and an &ldquo;Interested
Shareholder&rdquo; which is defined as a shareholder who, alone or with others, may exercise or direct the exercise of at least 10% of
the voting power of the corporation in the election of directors. The Ohio Merger Moratorium Statute prohibits such transactions between
the corporation and an Interested Shareholder for a period of three years after a person becomes an Interested Shareholder, unless, prior
to such date, the directors approved either the business combination or other transaction or approved the acquisition that caused the
person to become an Interested Shareholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">After the three-year period,
transactions between the corporation and the Interested Shareholder are permitted if:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15.1pt"></TD><TD STYLE="width: 20.9pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify">the transaction is approved by the holders of shares with at least two-thirds of the voting power of the
corporation in the election of directors or the approval of the holders of a majority of the voting shares held by persons other than
an Interested Shareholder; or&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15.1pt"></TD><TD STYLE="width: 20.9pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify">the business combination results in shareholders, other than the Interested Shareholder, receiving the
higher of the highest amount paid in the past by the Interested Shareholders for the corporation&rsquo;s shares or the amount that would
be due to the shareholders if the corporation were to dissolve.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The Ohio Merger Moratorium Statute
does not apply to a corporation if its articles of incorporation or code of regulations so provide. We have not opted out of the application
of the Ohio Merger Moratorium Statute.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify">Ohio Anti-Greenmail Statute</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">Pursuant to the Ohio Anti-Greenmail
Statute, a public corporation formed in Ohio may recover profits that a shareholder makes from the sale of the corporation&rsquo;s securities
within 18 months after making a proposal to acquire control or publicly disclosing the possibility of a proposal to acquire control. The
corporation may not, however, recover from a person who proves either: (i) that his sole purpose in making the proposal was to succeed
in acquiring control of the corporation and there were reasonable grounds to believe that he would acquire control of the corporation;
or (ii) that his purpose was not to increase any profit or decrease any loss in the shares. Also, before the corporation may obtain any
recovery, the aggregate amount of the profit realized by such person must exceed $250,000. Any shareholder may bring an action on behalf
of the corporation if a corporation refuses to bring an action to recover these profits.</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0in">The party bringing such an action
may recover his attorneys&rsquo; fees if the court having jurisdiction over such action orders recovery of any profits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The Ohio Anti-Greenmail Statute
does not apply to a corporation if its articles of incorporation or code of regulations so provide. We have not opted out of the application
of the Ohio Anti-Greenmail Statute.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_009"></A>USE OF PROCEEDS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="background-color: white">We
will not receive any proceeds from the shares of our Common Stock offered for resale by the Selling Shareholders. </FONT>We have agreed
to bear all of the expenses incurred in connection with the registration of the Common Stock covered by this prospectus and the Selling
Shareholders will pay or assume brokerage commissions and similar charges, if any, incurred in the sale of the shares of Common Stock.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_010"></A>SELLING SHAREHOLDERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in">On August
8, 2023, we entered into an Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;) with Axiom Test Equipment, LLC, a Delaware
limited liability company and wholly owned subsidiary of Transcat (&ldquo;Merger Sub&rdquo;), Axiom Test Equipment, Inc., a California
corporation (&ldquo;Axiom&rdquo;), Gary F. Shilts, trustee of the Shilts Family 2008 Trust, dated 5/6/2008 (the &ldquo;Shilts Trust&rdquo;),
Joshua Shilts (&ldquo;J. Shilts&rdquo;), Shannon Johnson, trustee of the Shannon and Gloria Johnson Living Trust (the &ldquo;Johnson Trust&rdquo;),
Lavon M. Parrish (&ldquo;Parrish,&rdquo; and together with the Shilts Trust, J. Shilts, and the Johnson Trust, the &ldquo;Selling Shareholders&rdquo;),
Gary F. Shilts, Shannon Johnson, and Joshua Shilts, as shareholder representative pursuant to which Axiom merged with and into the Merger
Sub. Founded in 2005, Axiom is a rental provider of Electronic Test Equipment to customers across the United States. Axiom has an in-house
ISO 17025 lab, which is primarily utilized for internal calibrations and equipment repair services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in">The
aggregate purchase price under the Merger Agreement was $38 million to be paid in a combination of $28 million in Common Stock and $10
million in cash. Of that amount, 271,820 shares of Common Stock were issued to the Selling Shareholders at closing and 43,583 shares of
Common Stock are subject to holdback provisions and will be issued in part after August 8, 2024 and in part after August 8, 2026, subject
to satisfaction of the conditions under the Merger Agreement. In connection with the Merger Agreement, we entered into the Registration
Rights Agreement with the Selling Shareholders pursuant to which we agreed to register for resale under the Securities Act the shares
of Common Stock issued pursuant to the Merger Agreement. Additionally, each of the Selling Shareholders entered into lock-up agreements
pursuant to which, subject to certain exceptions, they each agreed not to sell or otherwise dispose of 25% of their shares of Common Stock
until the effective date of the registration statement of which this prospectus forms a part, 25% of their shares of Common Stock until
90 days after the effective date of this registration statement of which this prospectus forms a part, and the remaining 50% of their
shares of Common Stock until 180 days after the effective date of the registration statement of which this prospectus forms a part, without
the prior written consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in">We have
agreed to bear all of the expenses incurred in connection with the registration of the Common Stock covered by this prospectus. The Selling
Shareholders will pay or assume brokerage commissions and similar charges, if any, incurred in the sale of the shares of Common Stock.</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in">This
prospectus covers the resale from time to time by the Selling Shareholders identified in the table below of an aggregate of up to 271,820
shares of our Common Stock, subject to any appropriate adjustment as a result of any stock split, stock dividend, or other distribution
with respect to, or in an exchange or replacement, or in connection with a combination of shares, distribution, recapitalization, merger,
consolidation, other reorganization or other similar event. Other than the transactions contemplated by the Merger Agreement, as described
above, the Selling Shareholders and their affiliates have not held a position or office, or had any material relationship, with us within
the last three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in">The
table below: (i)&nbsp;lists the Selling Shareholders and other information regarding the beneficial ownership (as determined under Section&nbsp;13(d)
of the Exchange Act and the rules and regulations thereunder) of our Common Stock by the Selling Shareholders; (ii)&nbsp;has been prepared
based upon information furnished to us by the Selling Shareholders; and (iii)&nbsp;to our knowledge, is accurate as of the date of this
prospectus. The Selling Shareholders may sell all, some or none of their securities in this offering. The Selling Shareholders identified
in the table below may have sold, transferred or otherwise disposed of some or all of their securities since the date of this prospectus
in transactions exempt from or not subject to the registration requirements of the Securities Act. Information concerning the Selling
Shareholders may change from time to time and, if necessary, we will amend or supplement this prospectus accordingly and as required.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: center"></TD>
    <TD STYLE="white-space: nowrap; text-align: center"></TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Shares Beneficially Owned<BR>
Prior to the Offering&nbsp;<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; white-space: nowrap; text-align: center"></TD>
    <TD ROWSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maximum<BR>
Number of Shares<BR>
to be sold in this<BR>
Offering</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; white-space: nowrap; text-align: center"></TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Shares Beneficially Owned<BR>
After the Offering&nbsp;<SUP>(1)(2)</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Selling Shareholders</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number </B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Percentage</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Percentage</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Gary F. Shilts, trustee of the Shilts Family 2008 Trust, dated 5/6/2008</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="width: 9%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">81,084</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.02%</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="width: 15%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">81,084</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="width: 9%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Joshua Shilts</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">28,568</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">*%</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">28,568</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Shannon Johnson, trustee of the Shannon and Gloria Johnson Living Trust</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">81,084</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.02%</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">81,084</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Lavon M. Parrish</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">81,084</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.02%</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">81,084</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 10pt"><B>TOTAL</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">271,820</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">3.41%</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">271,820</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.1in"></TD><TD STYLE="width: 0.15in">*</TD><TD>Represents less than 1%.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.1in"></TD><TD STYLE="width: 0.15in"><SUP>(1)</SUP></TD><TD STYLE="text-align: justify">Percentage ownership for the Selling Shareholders is determined in accordance with Section 13(d) of the Exchange Act and the rules
and regulations thereunder and is based on 7,970,868 outstanding shares of our Common Stock as of August 8, 2023.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.1in"></TD><TD STYLE="width: 0.15in"><SUP>(2)</SUP></TD><TD STYLE="text-align: justify">The totals reported in this column assume that (a) all of the securities registered by the registration statement of which this prospectus
is a part are sold in this offering; (b) the Selling Shareholders do not (i) sell any of the shares of Common Stock, if any, that have
been issued to it other than those covered by this prospectus; and (ii) acquire additional shares of our Common Stock after the date of
this prospectus and prior to the completion of this offering.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_011"></A>PLAN OF DISTRIBUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The Selling Shareholders, which
as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares of Common Stock or interests in shares
of Common Stock received after the date of this prospectus from a Selling Shareholder as a gift, pledge, partnership distribution or other
transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of Common Stock covered by this prospectus
on any stock exchange, market or trading facility on which the</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0in">shares of Common Stock are traded
or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related
to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The Selling Shareholders may
use any one or more of the following methods when disposing of the shares of Common Stock:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and
resell a portion of the block as principal to facilitate the transaction;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">an exchange distribution in accordance with the rules of the applicable exchange;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">privately negotiated transactions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">short sales effected after the date the registration statement of which this prospectus is a part is declared
effective by the SEC;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">through the writing or settlement of options or other hedging transactions, whether through an options
exchange or otherwise;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">broker-dealers may agree with the Selling Shareholders to sell a specified number of such shares at a
stipulated price per share;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the in-kind distribution of the shares by an investment fund to its limited partners, members or other
equity holders;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">a combination of any such methods of sale; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 33.1pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other method permitted by applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The Selling Shareholders may
sell all, some or none of the shares of Common Stock covered by this prospectus. If sold under the registration statement of which this
prospectus forms a part, the shares of Common Stock will be freely tradeable in the hands of persons other than our affiliates that acquire
such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The Selling Shareholders may,
from time to time, pledge or grant a security interest in some or all of the shares of Common Stock owned by them and, if they default
in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of Common Stock, from time
to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities
Act amending the list of Selling Shareholders to include the pledgee, transferee or other successors in interest as a Selling Shareholder
under this prospectus. The Selling Shareholders also may transfer the shares of Common Stock in other circumstances, in which case the
transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">In connection with the sale of
our Common Stock or interests therein, the Selling Shareholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the Common Stock in the course of hedging the positions it assumes. To the extent
permitted by applicable securities laws, the Selling Shareholders may also sell shares of our Common</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0in">Stock short and deliver these securities
to close out their short positions, or loan or pledge the Common Stock to broker-dealers that in turn may sell these securities. The Selling
Shareholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one
or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares of Common Stock
offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as
supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The aggregate proceeds to the
Selling Shareholders from the sale of the Common Stock offered by the Selling Shareholders will be the purchase price of the Common Stock
less discounts or commissions, if any. The Selling Shareholders reserve the right to accept and, together with their agents from time
to time, to reject, in whole or in part, any proposed purchase of Common Stock to be made directly or through agents. We will not receive
any of the proceeds from this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The Selling Shareholders also
may resell all or a portion of the shares of Common Stock in open market transactions in reliance upon Rule 144 under the Securities Act,
provided that it meets the criteria and conforms to the requirements of that rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The Selling Shareholders and
any underwriters, broker-dealers or agents that participate in the sale of the Common Stock or interests therein may be &ldquo;underwriters&rdquo;
within the meaning of Section 2(a)(11) of the Securities Act. Any discounts, commissions, concessions or profit it earns on any resale
of the shares of Common Stock covered by this prospectus may be underwriting discounts and commissions under the Securities Act. Selling
Shareholders who are &ldquo;underwriters&rdquo; within the meaning of Section 2(a)(11) of the Securities Act will be subject to the prospectus
delivery requirements of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">To the extent required, the shares
of our Common Stock to be sold, the names of the Selling Shareholders, the respective purchase prices and public offering prices, the
names of any agents, dealer or underwriter, any applicable commissions or discounts with respect to a particular offer will be set forth
in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this
prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">In order to comply with the securities
laws of some states, if applicable, the Common Stock may be sold in these jurisdictions only through registered or licensed brokers or
dealers. In addition, in some states the Common Stock may not be sold unless it has been registered or qualified for sale or an exemption
from registration or qualification requirements is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We have advised the Selling Shareholders
that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities
of the Selling Shareholders and their affiliates. In addition, to the extent applicable we will make copies of this prospectus (as it
may be supplemented or amended from time to time) available to the Selling Shareholders for the purpose of satisfying the prospectus delivery
requirements of the Securities Act. The Selling Shareholders may indemnify any broker-dealer that participates in transactions involving
the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We
have agreed to indemnify the Selling Shareholders against certain liabilities, including liabilities under the Securities Act and state
securities laws, relating to the registration of the shares offered by this prospectus.</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">We have agreed with the Selling
Shareholders to keep the registration statement of which this prospectus constitutes a part effective until the earliest to occur of (i)
February 8, 2026, (ii) a Change of Control, and (iii) such time as all the shares of Common Stock covered by this prospectus have been
sold by the Selling Shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">For purposes hereof, a &ldquo;Change
of Control&rdquo; means an event or series of events (i) as a result of which any &ldquo;person&rdquo; or &ldquo;group&rdquo; (as such
terms are used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &ldquo;beneficial owner&rdquo; (as defined in Rules 13d-3
and 13d-5 under the Exchange Act, except that a person or group shall be deemed to have &ldquo;beneficial ownership&rdquo; of all Common
Stock that such person or group has the right to acquire, whether such right is exercisable immediately or only after the passage of time
(such right, an &ldquo;option right&rdquo;)), directly or indirectly, of 50% or more of the Common Stock entitled to vote for members
of the Company&rsquo;s board of directors on a fully diluted basis (and taking into account all such Common Stock that such person or
group has the right to acquire pursuant to any option right); or (ii) that results in the sale of all or substantially all of the assets
or businesses of the Company and its consolidated subsidiaries, taken as a whole; provided, however that such event or events shall not
constitute a Change of Control if, following the occurrence thereof, shares of Common Stock continue to be listed for trading on any market
or exchange of The Nasdaq Stock Market LLC, or any other market or exchange on which the shares of Common Stock covered by this prospectus
are listed for trading.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_012"></A>LEGAL MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The validity of the securities
offered hereby will be passed upon for us by James M. Jenkins, General Counsel and VP of Corporate Development of the Company. As of August
8, 2023, Mr. Jenkins beneficially owned 7,398 shares of the Company&rsquo;s Common Stock, which represented less than 1.0% of the total
outstanding shares of Common Stock of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: center; text-indent: 0in"><A NAME="a_013"></A>EXPERTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15.1pt">The consolidated financial statements
of Transcat, Inc. as of March 25, 2023 and March 26, 2022, and for each of the years in the three-year period ended March 25, 2023, have
been incorporated by reference herein, in reliance upon the reports of Freed Maxick CPAs, P.C., independent registered public accounting
firm, and upon the authority of said firm as experts in accounting and auditing.</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 50pt; margin-left: 0pt; text-align: center"><IMG SRC="trns4234271-s3x1x1x1.jpg" ALT=""></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Transcat, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 30pt 0pt 45pt; text-align: center"><B>271,820 Shares of Common Stock Offered by the Selling
Shareholders<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 70pt 0pt; text-align: center"><B>August 25, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; text-align: justify; text-indent: 15pt">No dealer, salesperson or other
person is authorized to give any information or to represent anything not contained in this prospectus. You must not rely on any unauthorized
information or representations. This prospectus is an offer to sell only the shares of Common Stock offered hereby, but only under circumstances
and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>trns4234271-s3x1x1x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 trns4234271-s3x1x1x1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !6 2P# 2(  A$! Q$!_\0
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MG?M2?![XH?L\:]\//A!\9?#U[X/^(.B_"[1IM=\):A<0/-I<GB#QQ\2/%VF
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M)RY%&248J[:2=W9+HCWV50P8E<D]0>,\C@^O0#GMD=,@_P"?O_P<"VUO;_\
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M@X>&M0TXC,:PR,T>%D&?$OA\8XOB'\.+FZN8[:RA^(G@A+Z1H1<L+>Y\0V,
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MU35]>U3QG?RW#:CXFO[_ %VXU'6];NGNG>Z6/5/%GB'6IM-TZ>1A'8B[NXT
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MX.=[."M[O,[)\NZ?9G3^!;JRT_QUX'O[^2)+*#QKX3DU1Y!>1_8M!TS7]/\
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MIT2*Z6RK*S"-?.8R*9#_  =']AG]MH,53]D+]J!U#,%=_@1XUL'<9.':QOO
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MU#Q3=W^J>$O'*P:<C:KX,\&>9>BY>QLK:*2ZNA([(EM^N'_!>=XH_P#@F/\
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MOXBV?PV\?^)Y[6%TFM8]9\5G0Q\,[6X7,D/B*4ER%E:?\N_^"?ES9#_@B/\
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M_++]H#Q1^S1XK_9P_9%^(?A#XJ^+OCG^UQXM^(7AK6?VLO&?Q$^(7BSQQ<>
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5%>D8K\DBS1112&%%%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
